Generic Pharmaceutical Industry Taps Two PA Execs
Charting the future of public relations
Holmes Report
CEO

Generic Pharmaceutical Industry Taps Two PA Execs

The Generic Pharmaceutical Association has named Christine Simmon as vice president of policy & public affairs, and Suzanne Charleston as director of government relations.

Paul Holmes

WASHINGTON, D.C.—The Generic Pharmaceutical Association has named Christine Simmon as vice president of policy & public affairs, and Suzanne Charleston as director of government relations. The two join GPhA as the association gears up for a battle with pharmaceutical research companies over providing quicker access to generic versions of major drugs.

“President Bush has stated his commitment to improving consumer access to affordable generic drugs by removing barriers to competition,” says Kathleen Jaeger, GPhA’s President and CEO. “Congress has the mandate from the American public to address the high cost of prescription drugs. We are adding two seasoned individuals at this critical time to ensure that the voice of American consumers, who need more timely access to affordable generic medicines, is heard during this critical debate.”

Most recently, Simmon was a senior policy analyst at BlueCross BlueShield Association where she helped position the insurance industry as a leading voice on pharmaceutical cost and safety issues. Charleston was director of government affairs at the Pharmaceutical Care Management Association, where she represented pharmacy benefit managers.

View Style:

Load 3 More
comments powered by Disqus